top of page

AMEG

Actinobacteria Metabolic Engineering

Our Story

Actinomycetes are a well-known and very intensively examined group of bacteria. They have produced various antibiotics and antitumor drugs and are industrially used to produce antibiotics and agro chemicals. Despite them being thoroughly studied, a huge potential remains still to be revealed. Recent DNA deciphering efforts, where the entire genomes of actinomycetes have been sequenced, revealed that these bacteria remained a very rich source of new potentially active natural products.
 

Hence, a huge reservoir of bioactive molecules stays “hidden” in the numerous publicly available bacterial genomes and metagenomes, confirming the strong limitations of conventional approaches for novel drug discovery.

 

Therefore, the major challenge in the field is exploitation of this untapped genomic potential, and its conversion into bioactive chemical entities for their further development as drugs.


In our department we aim to apply a synthetic biology approaches and to develop a truly functional technology platform for discovery, bioengineering and sustainable supply those hidden in genomes compounds for pharmacological testing.

Research & Technology

We leverage machine learning technology to ensure precise data analysis and research.

1

Natural Product Discovery

12 ONGOING RESERCH PROJECTS

Use this space to promote the business, its products or its services. Help people become familiar with the business and its offerings, creating a sense of connection and trust. Focus on what makes the business unique and how users can benefit from choosing it.

2

Synthetic Biology

5 ONGOING RESERCH PROJECTS

Use this space to promote the business, its products or its services. Help people become familiar with the business and its offerings, creating a sense of connection and trust. Focus on what makes the business unique and how users can benefit from choosing it.

3

Biosynthetic Engineering of Actinomycetes

8 ONGOING RESERCH PROJECTS

Use this space to promote the business, its products or its services. Help people become familiar with the business and its offerings, creating a sense of connection and trust. Focus on what makes the business unique and how users can benefit from choosing it.

What We Stand For

Innovation, Health, Humanity.

Use this space to share a testimonial quote about the business, its products or its services. Insert a quote from a real customer or client here to build trust and win over site visitors. 

Megan Brown
CEO and Co-Founder of BGS

BGS in Numbers

75

Employees

$100

in Investments

224

Partners Worldwide

15

Publications

25

Ongoing Research Programs

Join Our Team

We’re looking for highly-motivated and talented people to join our innovative team. Submit your application today to join the BGS journey!

Senior Project Manager

San Francisco, CA

Associate Director, Drug Delivery

San Francisco, CA

Data Scientist, IT

San Francisco, CA

Press

BGS appoints Andrew Kim as Board Director

AGIAI Science Journal
November 2035

Therapeutics Giant Announces Collaboration With San Francisco’s BGS

Biotech Frontier Review
May 2035

There’s a New Kid in Town, Changing the Face of Genetic Engineering.

IBRM Magazine
March 2035

Join The BGS Newsletter

Be the first to receive the latest news and updates.

bottom of page